ReviewFrontiers in pharmacology2023

Advances in the study of marketed antibody-drug Conjugates (ADCs) for the treatment of breast cancer.

Yan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.